Announcement of the Kahoku Shimpo article on seminar by the “Sendai City x Tohoku University Smart Frontier Council Wellness Subcommittee” in relation to the XPRIZE Healthspan, a global longevity competition

In order to be selected as the TOP 10 (finalists) in late 2026 for the global longevity competition XPRIZE Healthspan¹⁾, and to ensure the success of the final clinical trial²⁾, a seminar was held on May 29, 2025 at the Tohoku University Graduate School of Medicine (Medicinal Hub) by the “Sendai City x Tohoku University Smart Frontier Council Wellness Subcommittee*,” and was featured in an article in the Kahoku Shimpo.

*https://sendai-tokku.jp/smart-frontier-sendai/

At the seminar, our Chairman Miyata Toshio, who is also the representative of the XPRIZE Healthspan Tohoku University team and a professor at the Tohoku University Graduate School of Medicine, gave a speech on the theme of “Tohoku University’s Challenge to XPRIZE Healthspan: Toward the Development of a Longevity Medicine.” In addition, Professor Harigae Hideo, Executive Vice President and Hospital Director of Tohoku University, who is the head of the XPRIZE Healthspan clinical trial, and some experts in cognition and locomotor functions gave speeches on themes related to the implementation of XPRIZE Healthspan clinical trials, after which about 90 participants from industry, government, and other sectors actively exchanged opinions.

Please see the following website for the Kahoku Shimpo article:
https://kahoku.news/articles/20250609khn000070.html

¹⁾XPRIZE Healthspan is a global competition hosted by the XPrize Foundation that aims to revolutionize therapeutic approaches to human longevity and tackle the challenging task of actively extending healthy lifespan by 10 years or more. The XPrize Foundation will pay a total of US$100 million to the research team that can extend healthy lifespan by 2030. The XPRIZE Foundation is a non-profit private foundation in the United States, and Elon Musk and others are among its sponsors. The foundation has held several competitions with prize money aimed at developing technologies that benefit humanity and solving global challenges, such as the world’s first private lunar exploration and a competition for carbon dioxide (CO2) capture and storage technology.

²⁾Final clinical trial of the XPRIZE Healthspan

A crossover clinical study that evaluates the effects of therapeutic intervention over a period of 4 years on approximately 100 people (up to 200 people) aged 50 or older. Compared to the control group, the intervention group must demonstrate at least 10 years of functional improvement in all three evaluation functions (muscles, cognition, and immunity).